SCHEMBL9937306

SCHEMBL9937306

CN([SiH](C)C)[Si](C)(C)C.FC(F)(F)c1ccc(C(=Cc2ccc(Br)cc2)c2ccc(Br)cc2)cc1.[NaH]

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 5/20 0.39
PTGS2 P35354 3/20 0.39
NQO2 P16083 1/20 0.39
GPR183 P32249 1/20 0.38
ERBB2 P04626 1/20 0.34
AKR1C3 P42330 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
CYP1A1 P04798 2/20 0.32
CYP1B1 Q16678 2/20 0.32
MAOB P27338 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2683560 0.82 PTGS1 (0.50) PTGS1PTGS2NQO2GPR183AKR1C3
SCHEMBL2683562 0.82 PTGS1 (0.50) PTGS1PTGS2NQO2GPR183AKR1C3
SCHEMBL9937304 0.81 PTGS1 (0.43) PTGS1PTGS2NQO2GPR183ERBB2
SCHEMBL28816901 0.73 KIF11 (0.47) PTGS1PTGS2NQO2GPR183AKR1C3
SCHEMBL28816900 0.73 KIF11 (0.47) PTGS1PTGS2NQO2GPR183AKR1C3
SCHEMBL2683558 0.70 ESR1 (0.47) PTGS2GPR183AKR1C3KDM4EALDH1A1
SCHEMBL2683557 0.70 ESR1 (0.47) PTGS2GPR183AKR1C3KDM4EALDH1A1
SCHEMBL21738730 0.69 ESR1 (0.62) PTGS2AKR1C3KDM4EALDH1A1MAPT
SCHEMBL13930403 0.67 MAPT (0.58) PTGS1PTGS2NQO2KDM4EALDH1A1
SCHEMBL6760853 0.65 PTGS2 (0.59) PTGS2GPR183AKR1C3KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651924-A1 ANTI-VIRAL COMPOUNDS Abbvie Inc. (US) 2013-10-23 EP disclosed
WO-2012083164-A1 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2012-06-21 WO disclosed